USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk — Norfolk, Virginia

USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk is a clinical research site located in Norfolk, Virginia, United States 23502-2824.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk has participated in 1 clinical trials.

Therapeutic areas: Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation.

Sponsors: TransThera Sciences (Nanjing), Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk?

USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk conducted?

USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk has 1 clinical trials on record. Their work covers Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation.

Is USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk accredited by Crixeo Health?

USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USO Oncology Network-Virginia Oncology Associates - Brock Cancer Center - Norfolk?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.